Parkinson's Disease

Contribute the innovation and join the research project aiming a developing early Parkinson's disease detection test. The Biotwin Parkinson's disease project is centered around the development of a non-invasive, at-home blood sampling technology designed for early detection of Parkinson's disease. The overarching goal of this research, spanning a duration of 12 months, is to assist healthcare practitioners with valuable insights to aid in clinical decision-making while simultaneously empowering patients in their battle against Parkinson's disease. Additionally, the project endeavors to refine prognosis methodologies and understand the development of Parkinson's disease. To achieve these objectives, the research project will leverage advanced biomarker profiling, bioinformatics, and machine learning algorithms. Participants in the study will provide at-home blood samples, which will then be analyzed to identify biomarkers profile correlating with Parkinson's disease.

To understand and improve outcomes for parkinson's disease.